Literature DB >> 29088318

Fever reaction and haemophagocytic syndrome induced by immune checkpoint inhibitors.

J-M Michot1, R Pruvost2, C Mateus3, S Champiat4, A-L Voisin5, A Marabelle4, O Lambotte6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29088318     DOI： 10.1093/annonc/mdx701

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  9 in total

1.  Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.

Authors:  Atsumasa Kurozumi; Hidenori Takahashi; Takayasu Watanabe; Yoshinobu Iwasaki
Journal:  Thorac Cancer       Date:  2021-03-30       Impact factor: 3.500

Review 2.  Nanotechnology-based immunotherapies to combat cancer metastasis.

Authors:  Yuping Zhao; Muhammad Bilal; Maimoona Qindeel; Muhammad Imran Khan; Kuldeep Dhama; Hafiz M N Iqbal
Journal:  Mol Biol Rep       Date:  2021-08-23       Impact factor: 2.316

3.  Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports.

Authors:  Roberta Noseda; Raffaela Bertoli; Laura Müller; Alessandro Ceschi
Journal:  J Immunother Cancer       Date:  2019-05-02       Impact factor: 13.751

4.  Robust delivery of RIG-I agonists using extracellular vesicles for anti-cancer immunotherapy.

Authors:  Boya Peng; Trinh Mai Nguyen; Migara Kavishka Jayasinghe; Chang Gao; Thach Tuan Pham; Luyen Tien Vu; Eric Yew Meng Yeo; Gracemary Yap; Lingzhi Wang; Boon Cher Goh; Wai Leong Tam; Dahai Luo; Minh Tn Le
Journal:  J Extracell Vesicles       Date:  2022-04

5.  Hemophagocytic lymphohistiocytosis in two patients following treatment with pembrolizumab: two case reports and a literature review.

Authors:  Yanqiu Wei; Wei He; Wei Sun; Chaojie Wu; Denghua Ren; Xinmin Wang; Mingshun Zhang; Mao Huang; Ningfei Ji
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496

Review 6.  Treatment-related hemophagocytic lymphohistiocytosis due to atezolizumab: a case report and review of the literature.

Authors:  Jaime Rubio-Perez; Ángel Ricardo Rodríguez-Perez; María Díaz-Blázquez; Victor Moreno-García; Manuel Dómine-Gómez
Journal:  J Med Case Rep       Date:  2022-10-04

Review 7.  Next generation of immune checkpoint therapy in cancer: new developments and challenges.

Authors:  Julian A Marin-Acevedo; Bhagirathbhai Dholaria; Aixa E Soyano; Keith L Knutson; Saranya Chumsri; Yanyan Lou
Journal:  J Hematol Oncol       Date:  2018-03-15       Impact factor: 17.388

8.  A case of pembrolizumab-induced hemophagocytic lymphohistiocytosis successfully treated with pulse glucocorticoid therapy.

Authors:  Hidenori Takahashi; Tomohiro Koiwa; Akira Fujita; Takayuki Suzuki; Amane Tagashira; Yoshinobu Iwasaki
Journal:  Respir Med Case Rep       Date:  2020-05-19

9.  Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review.

Authors:  Nabil E Omar; Kareem A El-Fass; Abdelrahman I Abushouk; Noha Elbaghdady; Abd Elmonem M Barakat; Ahmed E Noreldin; Dina Johar; Mohamed Yassin; Anas Hamad; Shereen Elazzazy; Said Dermime
Journal:  Front Immunol       Date:  2020-10-21       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.